Skip to main content
. 2021 Mar 10;87(8):3056–3068. doi: 10.1111/bcp.14768

TABLE 3.

Examples of warfarin dose initiation and dose adjustment guidelines for venous thromboembolism by SSA countries' departments or ministries of health

Guideline Warfarin dose initiation guideline Warfarin dose adjustment guideline
Ghana Standard Treatment Guidelines 201097 “Warfarin, oral, adults: 10 mg daily at 6 pm for 2 days, then 5 mg daily” “Regular dose adjustment and monitoring of INR until target of 2.0 and 3.0 is attained”
Namibia Standard Treatment Guidelines 201198 “Warfarin: 5 to 10 mg orally; start at same time as heparin” “Adjust dose according to INR”
Ethiopia Standard Treatment Guidelines for General Hospitals 201499 “Warfarin (starting simultaneously with heparin), 5 mg orally, daily” “Dose adjusted to achieve target INR of 2.0 to 3.0″
Uganda Clinical Guidelines. National Guidelines for Management of Common Conditions 2016100 “… plus warfarin 5 mg single dose given in the evening, commencing on the same day as heparin” “Maintenance dose 2.5 to 7.5 mg single dose daily, adjusted according to the INR 2 to 3″
Kenya National Guidelines for Cardiovascular Diseases Management 2018101 “Recommended starting dose: 5 mg orally once a day” “Typical maintenance dose: 2 to 10 mg orally once a day. Dosage must be individualized according to the patient's INR”
Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Adults 2019102

Day 1:

5 mg daily (2.5 mg daily for high sensitivity)

2‐3 d after initiation:

• 5‐7.5 mg/d if INR < 1.5

• 2.5‐5 mg/d if INR 1.5 to 1.9

• 2.5 mg/d if INR 2.0 to 2.5

• hold warfarin if INR > 2.5

2‐3 d after last INR check:

• 7.5‐10 mg/d if INR < 1.5

• 5‐10 mg/d if INR 1.5 to 1.9

• 2.5‐5 mg/d if INR 2.0 to 3.0

• hold warfarin if INR > 3

• Increase weekly dose by 10% if INR < 1.5

• Increase weekly dose by 5% if INR 1.5 to 1.9

• No change to warfarin dose if INR 2.0 to 3.0

• Decrease weekly dose by 5% if INR 3.1 to 4.0

• Decrease weekly dose by 10% if INR 4.1 to 5.0

• Decrease weekly dose by 20% if INR 5.1 to 9.0

INR, international normalised ratio.